OMNIPOD DASH, PODS 10-PACK
Report
- Report Number
- 3004464228-2023-07373
- Event Type
- Malfunction
- Date Received
- March 19, 2023
- Date of Event
- February 28, 2023
- Report Date
- March 11, 2023
- Manufacturer
- INSULET CORPORATION
- Product Code
- LZG
- PMA / PMN Number
- K211575
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MA, US
- Reporter Occupation
- OTHER
- Health Professional
- N
Narratives
ACCORDING TO THE COMPLAINANT THE DEVICE WILL NOT BE RETURNED FOR INVESTIGATION. WE ARE UNABLE TO CONFIRM THE BENT CANNULA OR TO DETERMINE IF IT COULD HAVE CONTRIBUTED TO THE REPORTED HYPERGLYCEMIA. LOT RELEASE RECORDS WERE REVIEWED AND THE PRODUCT LOT MET ALL ACCEPTANCE CRITERIA. SPECIFICALLY, A POD IS PAIRED TO A PDM AND PUT THROUGH SIMULATED USE TESTING INCLUDING CONFIRMING THE BLUE SOFT CANNULA IS INSPECTED FOR ANY DAMAGE.
THE RECEIVED DEVICE HAD THE CANNULA ASSEMBLY FULLY DEPLOYED. THE CANNULA MEASURED THE CORRECT FULL LENGTH ACCORDING TO SPECIFICATION AND DID NOT APPEAR BENT/KINKED. INSPECTION OF THE CANNULA ASSEMBLY FOUND NO EVIDENCE OF ANY DAMAGE OR MANUFACTURING DEFICIENCIES THAT WOULD RESULT IN THE DEVICE FAILING TO DELIVER INSULIN. DATA OBTAINED FROM THE DEVICE GENERATED AN 0X29 ALARM. THE ALARM INDICATED ALERT 0 HAD TRANSITIONED TO ALARM. ALERT 0 IS USED AS AUTO-OFF ALERT WHICH IS INTENDED TO FORCE THE USER TO COMMUNICATE WITH THE POD WITHIN A CERTAIN TIME INTERVAL SET BY THE USER. GENERATION OF THE ALARM STOPPED THE DELIVERY OF INSULIN.
IT WAS REPORTED THAT THE PATIENT'S BLOOD GLUCOSE (BG) LEVELS REACHED 16 MMOL/L (288 MG/DL) WHILE WEARING THE POD BETWEEN 36 AND 48 HOURS ON THE ABDOMEN. THE POD WAS REMOVED, AND THE CANNULA WAS NOTED TO BE BENT. A NEW POD WAS APPLIED TO TREAT THE HYPERGLYCEMIA.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 362001 | OMNIPOD DASH, PODS 10-PACK | PUMP, INFUSION, INSULIN | LZG | INSULET CORPORATION | PT-000029 | PD1K05262211 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 73 YR | Female |